Search

Search Constraints

You searched for: Author/Creator Curti, Brendan D

Search Results

1. Adoptive TIL in HPV-negative oral scca. (4th November 2015)

2. An evaluation of autologous tumor-reactive TIL generation from head and neck squamous cell cancers. (4th November 2015)

3. Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program. Issue 1 (14th May 2014)

4. Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor. Issue 4 (9th April 2021)

5. Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab. (4th November 2015)

7. Novel strategy to monitor apparent tumor-specific T cells in patients with cancer. (7th November 2013)

8. Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors. Issue 1 (20th January 2023)

10. Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment. (4th November 2015)